Full Text View
Tabular View
No Study Results Posted
Related Studies
Combination Chemotherapy Plus PSC-833 in Treating Children With Refractory or Relapsed Acute Leukemia
This study has been completed.
Study NCT00002912   Information provided by National Cancer Institute (NCI)
First Received: November 1, 1999   Last Updated: July 23, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Leukemia
More general conditions related to this trial
Neoplasms
Neoplasms by Histologic Type
Interventions listed in this trial
etoposide
mitoxantrone hydrochloride
valspodar
Additional drug interventions recognized in this trial
Etoposide phosphate
Mitoxantrone
More general drug interventions related to this trial
Analgesics
Antineoplastic Agents
Antineoplastic Agents, Phytogenic
Central Nervous System Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Pediatric Oncology Group
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services